Bafna Pharmaceuticals Ltd. - Research Center
532989 BAFNAPH Group (T) BSE data
Add to watchlist
| Results |
Quarterly
|
| Statement | |
| More |
Quarterly results in brief
(Rs crore)
| Mar' 24 | Dec' 23 | Sep' 23 | Jun' 23 | Mar' 23 | |
|---|---|---|---|---|---|
| Sales | 41.40 | 28.44 | 40.68 | 41.95 | 42.24 |
| Operating profit | 2.89 | -2.08 | 4.00 | 6.30 | 7.62 |
| Interest | 0.68 | 0.58 | 0.44 | 0.60 | 0.70 |
| Gross profit | 2.73 | -1.67 | 3.73 | 7.56 | 7.18 |
| EPS (Rs) | 0.62 | -1.24 | 1.05 | 2.68 | 2.27 |
Quarterly
results in details
| Mar' 24 | Dec' 23 | Sep' 23 | Jun' 23 | Mar' 23 | |
|---|---|---|---|---|---|
| Other income | 0.52 | 0.98 | 0.16 | 1.87 | 0.26 |
| Stock adjustment | -3.37 | -0.19 | 2.24 | -3.53 | 1.36 |
| Raw material | 23.79 | 16.00 | 19.67 | 19.56 | 19.72 |
| Power and fuel | - | - | - | - | - |
| Employee expenses | 5.38 | 4.53 | 4.85 | 4.27 | 4.57 |
| Excise | - | - | - | - | - |
| Admin and selling expenses | - | - | - | - | - |
| Research and development expenses | - | - | - | - | - |
| Expenses capitalised | - | - | - | - | - |
| Other expenses | 12.72 | 10.19 | 9.92 | 15.34 | 8.97 |
| Provisions made | - | - | - | - | - |
| Depreciation | 1.27 | 1.27 | 1.24 | 1.21 | 1.53 |
| Taxation | - | - | - | - | 0.28 |
| Net profit / loss | 1.46 | -2.94 | 2.48 | 6.35 | 5.37 |
| Extra ordinary item | - | - | - | - | - |
| Prior year adjustments | - | - | - | - | - |
| Equity capital | 23.66 | 23.66 | 23.66 | 23.66 | 23.66 |
| Equity dividend rate | - | - | - | - | - |
| Agg.of non-prom. shares (Lacs) | - | - | - | - | - |
| Agg.of non promotoholding (%) | - | - | - | - | - |
| OPM (%) | 6.97 | -7.30 | 9.84 | 15.01 | 18.04 |
| GPM (%) | 6.51 | -5.68 | 9.12 | 17.26 | 16.88 |
| NPM (%) | 3.47 | -10.00 | 6.08 | 14.49 | 12.64 |
© 2024 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback
DISCLAIMER: All financials are on standalone basis